Cargando…

Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates

BACKGROUND: Recent reports show that R70Q and L/C91M amino acid substitutions in the core from different hepatitis C virus (HCV) genotypes have been associated with variable responses to interferon (IFN) and ribavirin (RBV) therapy, as well to an increase of hepatocellular carcinoma (HCC) risk, live...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaspe, Rossana C, Sulbarán, Yoneira F, Sulbarán, Maria Z, Loureiro, Carmen L, Rangel, Hector R, Pujol, Flor H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511240/
https://www.ncbi.nlm.nih.gov/pubmed/22995142
http://dx.doi.org/10.1186/1743-422X-9-214
_version_ 1782251563756027904
author Jaspe, Rossana C
Sulbarán, Yoneira F
Sulbarán, Maria Z
Loureiro, Carmen L
Rangel, Hector R
Pujol, Flor H
author_facet Jaspe, Rossana C
Sulbarán, Yoneira F
Sulbarán, Maria Z
Loureiro, Carmen L
Rangel, Hector R
Pujol, Flor H
author_sort Jaspe, Rossana C
collection PubMed
description BACKGROUND: Recent reports show that R70Q and L/C91M amino acid substitutions in the core from different hepatitis C virus (HCV) genotypes have been associated with variable responses to interferon (IFN) and ribavirin (RBV) therapy, as well to an increase of hepatocellular carcinoma (HCC) risk, liver steatosis and insulin resistance (IR). Mutations in NS5B have also been associated to IFN, RBV, nucleoside and non-nucleoside inhibitors drug resistance. The prevalence of these mutations was studied in HCV RNA samples from chronically HCV-infected drug-naïve patients. METHODS: After amplification of core and NS5B region by nested-PCR, 12 substitutions were analyzed in 266 Venezuelan HCV isolates subtype 1a, 1b, 2a, 2c, 2b, 2j (a subtype frequently found in Venezuela) and 3a (n = 127 and n = 228 for core and NS5B respectively), and compared to isolates from other countries (n = 355 and n = 646 for core and NS5B respectively). RESULTS: R70Q and L/C91M core substitutions were present exclusively in HCV G1b. Both substitutions were more frequent in American isolates compared to Asian ones (69% versus 26%, p < 0.001 and 75% versus 45%, p < 0.001 respectively). In Venezuelan isolates NS5B D310N substitution was detected mainly in G3a (100%) and G1a (13%), this later with a significantly higher prevalence than in Brazilian isolates (p = 0.03). The NS5B mutations related to IFN/RBV treatment D244N was mainly found in G3a, and Q309R was present in all genotypes, except G2. Resistance to new NS5B inhibitors (C316N) was only detected in 18% of G1b, with a significantly lower prevalence than in Asian isolates, where this polymorphism was surprisingly frequent (p < 0.001). CONCLUSIONS: Genotypical, geographical and regional differences were found in the prevalence of substitutions in HCV core and NS5B proteins. The substitutions found in the Venezuelan G2j type were similar to that found in G2a and G2c isolates. Our results suggest a high prevalence of the R70Q and L/C91M mutations of core protein for G1b and D310N substitution of NS5B protein for the G3a. C316N polymorphism related with resistance to new NS5B inhibitors was only found in G1b. Some of these mutations could be associated with a worse prognosis of the disease in HCV infected patients.
format Online
Article
Text
id pubmed-3511240
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35112402012-12-01 Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates Jaspe, Rossana C Sulbarán, Yoneira F Sulbarán, Maria Z Loureiro, Carmen L Rangel, Hector R Pujol, Flor H Virol J Research BACKGROUND: Recent reports show that R70Q and L/C91M amino acid substitutions in the core from different hepatitis C virus (HCV) genotypes have been associated with variable responses to interferon (IFN) and ribavirin (RBV) therapy, as well to an increase of hepatocellular carcinoma (HCC) risk, liver steatosis and insulin resistance (IR). Mutations in NS5B have also been associated to IFN, RBV, nucleoside and non-nucleoside inhibitors drug resistance. The prevalence of these mutations was studied in HCV RNA samples from chronically HCV-infected drug-naïve patients. METHODS: After amplification of core and NS5B region by nested-PCR, 12 substitutions were analyzed in 266 Venezuelan HCV isolates subtype 1a, 1b, 2a, 2c, 2b, 2j (a subtype frequently found in Venezuela) and 3a (n = 127 and n = 228 for core and NS5B respectively), and compared to isolates from other countries (n = 355 and n = 646 for core and NS5B respectively). RESULTS: R70Q and L/C91M core substitutions were present exclusively in HCV G1b. Both substitutions were more frequent in American isolates compared to Asian ones (69% versus 26%, p < 0.001 and 75% versus 45%, p < 0.001 respectively). In Venezuelan isolates NS5B D310N substitution was detected mainly in G3a (100%) and G1a (13%), this later with a significantly higher prevalence than in Brazilian isolates (p = 0.03). The NS5B mutations related to IFN/RBV treatment D244N was mainly found in G3a, and Q309R was present in all genotypes, except G2. Resistance to new NS5B inhibitors (C316N) was only detected in 18% of G1b, with a significantly lower prevalence than in Asian isolates, where this polymorphism was surprisingly frequent (p < 0.001). CONCLUSIONS: Genotypical, geographical and regional differences were found in the prevalence of substitutions in HCV core and NS5B proteins. The substitutions found in the Venezuelan G2j type were similar to that found in G2a and G2c isolates. Our results suggest a high prevalence of the R70Q and L/C91M mutations of core protein for G1b and D310N substitution of NS5B protein for the G3a. C316N polymorphism related with resistance to new NS5B inhibitors was only found in G1b. Some of these mutations could be associated with a worse prognosis of the disease in HCV infected patients. BioMed Central 2012-09-21 /pmc/articles/PMC3511240/ /pubmed/22995142 http://dx.doi.org/10.1186/1743-422X-9-214 Text en Copyright ©2012 Jaspe et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Jaspe, Rossana C
Sulbarán, Yoneira F
Sulbarán, Maria Z
Loureiro, Carmen L
Rangel, Hector R
Pujol, Flor H
Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates
title Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates
title_full Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates
title_fullStr Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates
title_full_unstemmed Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates
title_short Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates
title_sort prevalence of amino acid mutations in hepatitis c virus core and ns5b regions among venezuelan viral isolates and comparison with worldwide isolates
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511240/
https://www.ncbi.nlm.nih.gov/pubmed/22995142
http://dx.doi.org/10.1186/1743-422X-9-214
work_keys_str_mv AT jasperossanac prevalenceofaminoacidmutationsinhepatitiscviruscoreandns5bregionsamongvenezuelanviralisolatesandcomparisonwithworldwideisolates
AT sulbaranyoneiraf prevalenceofaminoacidmutationsinhepatitiscviruscoreandns5bregionsamongvenezuelanviralisolatesandcomparisonwithworldwideisolates
AT sulbaranmariaz prevalenceofaminoacidmutationsinhepatitiscviruscoreandns5bregionsamongvenezuelanviralisolatesandcomparisonwithworldwideisolates
AT loureirocarmenl prevalenceofaminoacidmutationsinhepatitiscviruscoreandns5bregionsamongvenezuelanviralisolatesandcomparisonwithworldwideisolates
AT rangelhectorr prevalenceofaminoacidmutationsinhepatitiscviruscoreandns5bregionsamongvenezuelanviralisolatesandcomparisonwithworldwideisolates
AT pujolflorh prevalenceofaminoacidmutationsinhepatitiscviruscoreandns5bregionsamongvenezuelanviralisolatesandcomparisonwithworldwideisolates